Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No Severe Congenital Anomalies”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableLooking for participantsNCT06425666
What this trial is testing

Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy

Who this might be right for
Cataract SurgeryCataract and Fuchs Endothelial Corneal Dystrophy
University of Cologne 120
Large-scale testing (Phase 3)Study completedNCT03131648
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 802
Not applicableStudy completedNCT00922597
What this trial is testing

Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery

Who this might be right for
Hemophilia A
Bayer 26
Early research (Phase 1)UnknownNCT01207869
What this trial is testing

Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia

Who this might be right for
Bronchopulmonary DysplasiaExtremely Premature InfantsSevere BPD That Conventional Therapies Has Failed+2 more
China Medical University Hospital 10
Large-scale testing (Phase 3)Study completedNCT03872401
What this trial is testing

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

Who this might be right for
Coronary Heart Disease (CHD)
Amgen 12,301
Large-scale testing (Phase 3)Looking for participantsNCT05392894
What this trial is testing

RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
King's College Hospital NHS Trust 120
Large-scale testing (Phase 3)UnknownNCT04776993
What this trial is testing

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy

Who this might be right for
Graves' Orbitopathy
University of Pisa 52
Testing effectiveness (Phase 2)Study completedNCT05388760
What this trial is testing

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

Who this might be right for
Atopic Dermatitis
LEO Pharma 28
Testing effectiveness (Phase 2)Study completedNCT01410019
What this trial is testing

Gene Therapy for X-linked Severe Combined Immunodeficiency

Who this might be right for
X-linked Severe Combined Immunodeficiency
Assistance Publique - Hôpitaux de Paris 5
Testing effectiveness (Phase 2)Study completedNCT03562377
What this trial is testing

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Who this might be right for
Atopic Dermatitis
LEO Pharma 215
Large-scale testing (Phase 3)Study completedNCT03160885
What this trial is testing

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Who this might be right for
Atopic Dermatitis
LEO Pharma 794
Not applicableStudy completedNCT04577898
What this trial is testing

RHA® Redensity Eye Versus No-treatment for the Infra-Orbital Hollows

Who this might be right for
Infra-orbital HollowsTear-trough DeformityWrinkle
Teoxane SA 248
Large-scale testing (Phase 3)Study completedNCT03526861
What this trial is testing

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

Who this might be right for
Atopic Dermatitis
LEO Pharma 301